SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 635 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 635 | -31.2% | 0.00% | – |
| Q2 2022 | $3,000 | -72.7% | 923 | -54.6% | 0.00% | – |
| Q1 2022 | $11,000 | -26.7% | 2,035 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | -11.8% | 2,035 | +2.2% | 0.00% | – |
| Q3 2021 | $17,000 | +240.0% | 1,991 | +298.2% | 0.00% | – |
| Q2 2021 | $5,000 | -86.5% | 500 | -83.3% | 0.00% | – |
| Q1 2021 | $37,000 | +3600.0% | 3,000 | +2900.0% | 0.00% | – |
| Q4 2020 | $1,000 | -88.9% | 100 | -90.1% | 0.00% | – |
| Q3 2020 | $9,000 | 0.0% | 1,010 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +800.0% | 1,010 | +910.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |